Premium
Management of metastatic prostate cancer
Author(s) -
Rosenthal Mark A
Publication year - 1998
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1998.tb141478.x
Subject(s) - medicine , palliative care , prostate cancer , quality of life (healthcare) , disease , intensive care medicine , multidisciplinary approach , radiation therapy , cancer , oncology , nursing , social science , sociology
Metastatic prostate cancer remains an incurable disease. However, palliative treatment based on hormonal manipulation can effectively control symptoms and prolong life. The development of progessive "hormone‐refractory disease" requires a multidisciplinary approach, with the involvement of general practitioners, urologists, radiation oncologists, medical oncologists and palliative care physicians. Some of the newer therapies, such as chemotherapy, have proved successful in improving the quality of life for many patients, and modern palliative care techniques can provide good symptom control.